1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea

C33H52N4O7S — CID 163916444

IUPAC1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea
SMILESCCCCC1(CCCC)CS(=O)(=O)c2ccc(N(C)C)cc2[C@@H](c2cccc(NC(=O)NC[C@H](O)[C@@H](C)[C@H](O)[C@H](O)CO)c2)N1
InChIInChI=1S/C33H52N4O7S/c1-6-8-15-33(16-9-7-2)21-45(43,44)29-14-13-25(37(4)5)18-26(29)30(36-33)23-11-10-12-24(17-23)35-32(42)34-19-27(39)22(3)31(41)28(40)20-38/h10-14,17-18,22,27-28,30-31,36,38-41H,6-9,15-16,19-21H2,1-5H3,(H2,34,35,42)/t22-,27+,28-,30-,31+/m1/s1
InChIKeyQWRBKUTXTUJPAK-SHQUAMPASA-N
MW648.87 g/mol
LogP3.17
Rot. Bonds15

About 1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea

1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea (PubChem CID 163916444) has the molecular formula C33H52N4O7S and a molecular weight of 648.87 g/mol. Its IUPAC name is 1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea.

Molecular Properties

Compound Name1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea
PubChem CID163916444
Molecular FormulaC33H52N4O7S
Molecular Weight648.87 g/mol
Exact Mass648.36
IUPAC Name1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea
SMILESCCCCC1(CCCC)CS(=O)(=O)c2ccc(N(C)C)cc2[C@@H](c2cccc(NC(=O)NC[C@H](O)[C@@H](C)[C@H](O)[C@H](O)CO)c2)N1
InChIInChI=1S/C33H52N4O7S/c1-6-8-15-33(16-9-7-2)21-45(43,44)29-14-13-25(37(4)5)18-26(29)30(36-33)23-11-10-12-24(17-23)35-32(42)34-19-27(39)22(3)31(41)28(40)20-38/h10-14,17-18,22,27-28,30-31,36,38-41H,6-9,15-16,19-21H2,1-5H3,(H2,34,35,42)/t22-,27+,28-,30-,31+/m1/s1
InChIKeyQWRBKUTXTUJPAK-SHQUAMPASA-N
XLogP3.17
TPSA171.46 Ų
H-Bond Donors7
H-Bond Acceptors9
Rotatable Bonds15
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500648.87
LogP ≤ 53.17
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 109

Analyze 1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea?
The IUPAC name of 1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea (CID 163916444) is 1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea.
What is the SMILES notation for 1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea?
The canonical SMILES for 1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea is CCCCC1(CCCC)CS(=O)(=O)c2ccc(N(C)C)cc2[C@@H](c2cccc(NC(=O)NC[C@H](O)[C@@H](C)[C@H](O)[C@H](O)CO)c2)N1.
What is the InChIKey of 1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea?
The InChIKey is QWRBKUTXTUJPAK-SHQUAMPASA-N. The full InChI is InChI=1S/C33H52N4O7S/c1-6-8-15-33(16-9-7-2)21-45(43,44)29-14-13-25(37(4)5)18-26(29)30(36-33)23-11-10-12-24(17-23)35-32(42)34-19-27(39)22(3)31(41)28(40)20-38/h10-14,17-18,22,27-28,30-31,36,38-41H,6-9,15-16,19-21H2,1-5H3,(H2,34,35,42)/t22-,27+,28-,30-,31+/m1/s1.
What are the key properties of 1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea?
1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea has a molecular weight of 648.87 g/mol, XLogP of 3.17, 15 rotatable bonds, 7 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-[(5R)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1λ6,4-benzothiazepin-5-yl]phenyl]-3-[(2R,3R,4S,5R)-2,4,5,6-tetrahydroxy-3-methylhexyl]urea is sourced from PubChem (CID 163916444), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).